Found: 10
Select item for more details and to access through your institution.
Olaparib is effective in combination with, and as maintenance therapy after, first‐line endocrine therapy in prostate cancer cells.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 561, doi. 10.1002/1878-0261.12185
- By:
- Publication type:
- Article
Biomarker potential of <italic>ST6GALNAC3</italic> and <italic>ZNF660</italic> promoter hypermethylation in prostate cancer tissue and liquid biopsies.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 545, doi. 10.1002/1878-0261.12183
- By:
- Publication type:
- Article
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 441, doi. 10.1002/1878-0261.12170
- By:
- Publication type:
- Article
CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 529, doi. 10.1002/1878-0261.12179
- By:
- Publication type:
- Article
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 495, doi. 10.1002/1878-0261.12177
- By:
- Publication type:
- Article
Activation of TNF‐α/NF‐κB axis enhances CRL4B<sup>DCAF</sup><sup>11</sup> E3 ligase activity and regulates cell cycle progression in human osteosarcoma cells.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 476, doi. 10.1002/1878-0261.12176
- By:
- Publication type:
- Article
A robust gene signature for the prediction of early relapse in stage I–III colon cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 463, doi. 10.1002/1878-0261.12175
- By:
- Publication type:
- Article
Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 423, doi. 10.1002/1878-0261.12167
- By:
- Publication type:
- Article
STAT1 is a sex‐specific tumor suppressor in colitis‐associated colorectal cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 514, doi. 10.1002/1878-0261.12178
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 4, p. 421, doi. 10.1002/1878-0261.12123
- Publication type:
- Article